AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
The chapter discusses the difficulties of managing cash in the biotech industry due to high costs, accelerated cash burn rates during clinical trials, and the crucial role of future funding. The guest, Alan Shaw, brings expertise in biotech finance management and the conversation explores resource allocation and cash management fundamentals.